Search
for
Sort by
Research 361–390 of 455
- Anatomy and Biology of Hair at Different Ages
- Long-acting microneedle formulations
- Somatotropin Penetration Testing from Formulations Applied Topically to the Skin
- Keratin 79 is a PPARA target that is highly expressed by liver damage
- Topological Distribution of Wound Stiffness Modulates Wound-Induced Hair Follicle Neogenesis
- In Vitro Hair Dermal Papilla Cells Induction by Fagraea berteroana, a Tree of the Marquesan Cosmetopoeia (French Polynesia)
- Therapeutic Potential of Chitosan-Based and Related Nanocomposite Systems in Wound Management: A Review
- An Insight on Ellagic Acid Formulations for the Management of Skin Diseases
- Whole blood transcriptome profiling identifies candidate genes associated with alopecia in male giant pandas (Ailuropoda melanoleuca)
- Hydrogels: current biomedical applications and future directions
- Biopolymer-Based Hydrogels for Wound Healing: Advances in Cellulose, Chitosan, Alginate, and Hyaluronic Acid from Design to Clinical Translation
- An Overview of Chitosan-Based Composites Containing Silver or Zinc Oxide Nanoparticles: Antimicrobial and Antibacterial Properties, and Biomedical Perspectives
- Cyclodextrin-Grafted Polysaccharides as Sustainable Platforms for Biomedical and Environmental Applications
- Black hair dye dermatitis: Still a major skin problem and commonly mimicking chronic actinic dermatitis
- Low-Molecular-Weight Fish Collagen Peptide Enhances Hair Regrowth via Activation of Proliferative Signaling and Suppression of Inhibitory Pathways
- Pathological Skin Scarring: From Mechanism to Targeted Local Therapy
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- Industry updates in advanced therapy medicinal products and regenerative medicine – March 2026
- N‑K GM SERIES: COMPLETE GEOMETRIC MEDICINE FOR SUDAN AND THE AFLATOXIN BELT — A Unified Solution for Aflatoxin Poisoning, Cancer, and Public Health Transformation
- N‑K GM SERIES: COMPLETE GEOMETRIC MEDICINE FOR SUDAN AND THE AFLATOXIN BELT — A Unified Solution for Aflatoxin Poisoning, Cancer, and Public Health Transformation
- Bio‐active designed peptide for hair keratin strengthening
- Bioactive Nutritional Macromolecules Supporting Hair Structure, Density, and Growth: A Comprehensive Review
- Nano-Enabled CRISPR-Cas Gene Editing for Cancer Therapeutics
- Recent Progress and Morphological Distribution of Polydopamine-Based Biomaterials and Their Applications
- Progress in the Expression, Purification, and Characterization of Recombinant Collagen
- Multifunctional hydrogel based on oxidized sodium alginate and carboxymethyl chitosan delivers minoxidil loaded liposomes for the treatment of androgenetic alopecia
- Hair
- RNA modifications: molecular orchestrators of wound healing
- A Systematic Review of the Mechanisms and Therapeutic Applications of GHK-Cu (Glycyl-L-Histidyl-L-Lysine-Copper Complex) in Topical Microneedle Delivery: A Case for Expanded Clinical Trials